Shares of Eli Lilly soared Thursday morning after the pharmaceutical giant announced a clinical trial of its once-daily ...

A daily weight loss pill being tested by Eli Lilly could work as well as its GLP-1 injection counterparts like Ozempic, ...

Patients on the new pill also lost weight — up to 16 pounds without reaching a plateau at the study’s end. Side effects were ...

The first GLP-1 pill could be in medicine cabinets sooner than expected. Eli Lilly (LLY) announced Thursday that its daily ...

A new weight-loss pill taken daily could compete with injections like Ozempic, research suggests. Patients, who all were ...

A daily weight loss pill that works like breakthrough fat jab Ozempic could be available in the UK as early as next year.

More than 2 in 5 adults in the US are grappling with ... a hassle-free and effective alternative to other weight-loss drugs such as Ozempic and Mounjaro. In a 40-week Phase 3 trial, they studied ...

The U.S. Food and Drug Administration on Monday warned consumers and pharmacies that fake versions of Ozempic, a drug to ...

injectable weight-loss medications, Ozempic and Wegovy. There are different GLP-1 molecules. But emerging data suggest semaglutide, the active compound in Ozempic and Wegovy, can lead to the same ...

In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic and Mounjaro, the pharmaceutical company says.

Other weight loss drugs must be injected, meaning the new pill from pharmaceutical giant Eli Lilly could become patients’ top ...